Pipeline Indications

Neuroparticle™ is committed to fulfilling an unmet global need for non-invasive addiction treatment, pain treatment, memory enhancement, mood treatment and brain/machine interfacing. The company has broad experience in creating FDA-approved devices used by more than a million people in companies that have raised over $100 million.

First Market

The first application for the Neuroparticle™ technology is non-invasive treatment for addiction, a $40 billion market.

Follow-On Markets

Subsequent applications will include non-invasive approaches to the many other neurological conditions currently being considered or already reimbursed for treatment with deep brain stimulation, as well as for brain-machine interfaces.

Potential follow-on markets for product

We are located at:Neuroparticle™ Corporation12156 Parklawn DriveNorth Bethesda MD 20852301-346-7944